Soy Processing and Food Allergy

March 16, 2026 updated by: University of Zurich

Impact of Soy Processing Methods on Clinical Allergenicity (Short Title: Soy Processing and Food Allergy)

Soy allergies are widespread and are becoming increasingly significant today as people around the world consume more and more soy and soy-containing foods. Soy is used in many products and undergoes various processing steps such as heating, extraction, enzymatic degradation, and preservation. However, it is not yet fully understood how these processing steps affect soy's ability to trigger allergic reactions.

The goal of this project is to process soy in various controlled ways and investigate how these methods affect its allergenic potential. First, the effects will be tested in the laboratory (in vitro). Subsequently, the results will be examined in humans using a skin prick test (SPT) to determine how the processed soy affects allergic reactions

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

Soy allergies are widespread and of particular concern, as the consumption of soy and soy products is increasing worldwide. Soy is processed in various ways for many foods, such as through heating, extraction, hydrolysis, and preservation. To date, little is known about the extent to which these processing steps influence the allergenicity of soy.

In this open-label, non-randomized, comparative, prospective, single-center clinical study, we aim to investigate the effects of the aforementioned processing steps on allergenicity. The project consists of various modules. The experimental parts will examine how soy can be modified through the processing steps mentioned above and how these steps can be integrated into the production of soy products. In the clinical part, the allergenicity of the modified soy products will first be tested in vitro and subsequently in skin tests.

Study Type

Interventional

Enrollment (Estimated)

55

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Age 18-75
  • Signed informed consent
  • primary soy allergy or secondary soy allergy or control (no soy allergy)

Exclusion Criteria:

  • Use of antihistamines within 3 days, systemic corticosteroids within 2 weeks, topical corticosteroids (test area) 1 week prior
  • Use of immunosuppressive or biologic agents
  • Active malignancy / ongoing treatment for a malignancy
  • Active or recurrent bacterial, fungal, or viral infection
  • Pregnancy
  • Drug or alcohol abuse, or any condition likely to impair compliance (e.g., language barrier, cognitive disorder, psychological illness)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: primary soy allergy
in-vitro-tests and skin prick test (SPT) in patients with primary soy allergy
skin prick test according SOPs
Other: secondary soy allergy
in-vitro-tests and skin prick test (SPT) in patients with secondary soy allergy
skin prick test according SOPs
Other: controls
in-vitro-tests and skin prick test (SPT) in participants without soy allergy
skin prick test according SOPs

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Frequency of sensitization (in vitro/in vivo) to processed soy proteins
Time Frame: one-time (in-vitro diagnostic/skin prick test)
Frequency of sensitization (in vitro/in vivo) to processed soy proteins compared to unprocessed soy proteins in patients with known soy allergy
one-time (in-vitro diagnostic/skin prick test)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sensitization patterns in primary and secondary soy allergy
Time Frame: one time (skin prick test, in vitro diagnostic)
Compare sensitization patterns between primary and secondary soy allergy to processed soy proteins
one time (skin prick test, in vitro diagnostic)
Degree of sensitization of soy allergic patients;
Time Frame: one time (skin prick test)
Degree of sensitization of soy allergic patients;
one time (skin prick test)
Correlation with clinical characteristics
Time Frame: one time (skin prick test)
Correlation of sensitizations with clinical characteristics (such as severity of reaction, type of soy allergy)
one time (skin prick test)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Marie-Charlotte Brüggen, MD PhD, University of Zurich

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

May 31, 2026

Primary Completion (Estimated)

August 31, 2028

Study Completion (Estimated)

August 31, 2029

Study Registration Dates

First Submitted

March 16, 2026

First Submitted That Met QC Criteria

March 16, 2026

First Posted (Actual)

March 20, 2026

Study Record Updates

Last Update Posted (Actual)

March 20, 2026

Last Update Submitted That Met QC Criteria

March 16, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Soy Allergy

Clinical Trials on Skin prick test (SPT)

Subscribe